Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Incyte Corp (NASDAQ:INCY)

102.96
Delayed Data
As of Jul 30
 -0.78 / -0.75%
Today’s Change
43.86
Today|||52-Week Range
121.70
+40.83%
Year-to-Date
No recent news for Incyte Corp.

Today’s Trading

Previous close103.74
Today’s open102.96
Day’s range-- - --
Volume1,120,978
Average volume (3 months)961,011
Market cap$18.6B
Dividend yield--
Data as of 07/30/2015

Growth & Valuation

Earnings growth (last year)+48.21%
Earnings growth (this year)+7.30%
Earnings growth (next 5 years)+219.00%
Revenue growth (last year)+44.10%
P/E ratioNM
Price/Sales24.01
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ENDPEndo International P...-0.23-0.27%
HSPHospira Inc-0.02-0.02%
MNKMallinckrodt Plc-1.03-0.84%
BMRNBiomarin Pharmaceuti...+0.24+0.17%
Data as of 07/30/2015

Financials

Next reporting dateAugust 4, 2015
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$511.5M
Annual profit (last year)-$48.5M
Net profit margin-9.48%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts